The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition

Ren-Qi Huang, Suzy A. Griffin, Michelle Taylor, Suwanna Vangveravong, Robert H. Mach, Glenn H. Dillon, Robert T. Luedtke

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

SV 293 [1-([5-methoxy-1H-indol-3-yl]methyl)-4-(4-[methylthio]phenyl)piperidin-4-ol] binds with 100-fold higher affinity to human D2 receptors compared to the human D3 and D4 dopamine receptor subtypes. We investigated the intrinsic efficacy of this compound at the D2 dopamine receptor subtype using both: (1) a forskolin-dependent adenylyl cyclase inhibition assay and (2) an electrophysiological assay for evaluating coupling to G-protein-coupled inwardly rectifying potassium channels. In both assays SV 293 was found to be a neutral antagonist capable of blocking the effects of the full D2-like receptor agonist quinpirole. Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalPharmacology
Volume92
Issue number1-2
DOIs
StatePublished - 1 Jan 2013

Fingerprint

Adenylyl Cyclases
Dopamine D2 Receptors
G Protein-Coupled Inwardly-Rectifying Potassium Channels
Dopamine D4 Receptors
Dopamine D3 Receptors
Quinpirole
Movement Disorders
Colforsin
Nervous System Diseases
Pharmacology
1-((5-methoxy-1H-indol-3-yl)methyl)-4-(4-(methylthio)phenyl)piperidin-4-ol
Dopamine D2 Receptor Antagonists

Keywords

  • Antagonist binding
  • Dopamine receptors
  • G-protein-coupled inwardly rectifying potassium
  • Patch clamp

Cite this

Huang, Ren-Qi ; Griffin, Suzy A. ; Taylor, Michelle ; Vangveravong, Suwanna ; Mach, Robert H. ; Dillon, Glenn H. ; Luedtke, Robert T. / The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. In: Pharmacology. 2013 ; Vol. 92, No. 1-2. pp. 84-89.
@article{9b912ef3fa8e4f52b97cf8bcf2a76a00,
title = "The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition",
abstract = "SV 293 [1-([5-methoxy-1H-indol-3-yl]methyl)-4-(4-[methylthio]phenyl)piperidin-4-ol] binds with 100-fold higher affinity to human D2 receptors compared to the human D3 and D4 dopamine receptor subtypes. We investigated the intrinsic efficacy of this compound at the D2 dopamine receptor subtype using both: (1) a forskolin-dependent adenylyl cyclase inhibition assay and (2) an electrophysiological assay for evaluating coupling to G-protein-coupled inwardly rectifying potassium channels. In both assays SV 293 was found to be a neutral antagonist capable of blocking the effects of the full D2-like receptor agonist quinpirole. Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated.",
keywords = "Antagonist binding, Dopamine receptors, G-protein-coupled inwardly rectifying potassium, Patch clamp",
author = "Ren-Qi Huang and Griffin, {Suzy A.} and Michelle Taylor and Suwanna Vangveravong and Mach, {Robert H.} and Dillon, {Glenn H.} and Luedtke, {Robert T.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1159/000351971",
language = "English",
volume = "92",
pages = "84--89",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "1-2",

}

The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition. / Huang, Ren-Qi; Griffin, Suzy A.; Taylor, Michelle; Vangveravong, Suwanna; Mach, Robert H.; Dillon, Glenn H.; Luedtke, Robert T.

In: Pharmacology, Vol. 92, No. 1-2, 01.01.2013, p. 84-89.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition

AU - Huang, Ren-Qi

AU - Griffin, Suzy A.

AU - Taylor, Michelle

AU - Vangveravong, Suwanna

AU - Mach, Robert H.

AU - Dillon, Glenn H.

AU - Luedtke, Robert T.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - SV 293 [1-([5-methoxy-1H-indol-3-yl]methyl)-4-(4-[methylthio]phenyl)piperidin-4-ol] binds with 100-fold higher affinity to human D2 receptors compared to the human D3 and D4 dopamine receptor subtypes. We investigated the intrinsic efficacy of this compound at the D2 dopamine receptor subtype using both: (1) a forskolin-dependent adenylyl cyclase inhibition assay and (2) an electrophysiological assay for evaluating coupling to G-protein-coupled inwardly rectifying potassium channels. In both assays SV 293 was found to be a neutral antagonist capable of blocking the effects of the full D2-like receptor agonist quinpirole. Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated.

AB - SV 293 [1-([5-methoxy-1H-indol-3-yl]methyl)-4-(4-[methylthio]phenyl)piperidin-4-ol] binds with 100-fold higher affinity to human D2 receptors compared to the human D3 and D4 dopamine receptor subtypes. We investigated the intrinsic efficacy of this compound at the D2 dopamine receptor subtype using both: (1) a forskolin-dependent adenylyl cyclase inhibition assay and (2) an electrophysiological assay for evaluating coupling to G-protein-coupled inwardly rectifying potassium channels. In both assays SV 293 was found to be a neutral antagonist capable of blocking the effects of the full D2-like receptor agonist quinpirole. Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated.

KW - Antagonist binding

KW - Dopamine receptors

KW - G-protein-coupled inwardly rectifying potassium

KW - Patch clamp

UR - http://www.scopus.com/inward/record.url?scp=84884255563&partnerID=8YFLogxK

U2 - 10.1159/000351971

DO - 10.1159/000351971

M3 - Article

VL - 92

SP - 84

EP - 89

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 1-2

ER -